Identifying genetic variants and the role they play in predisposing people to Alzheimer’s disease can help researchers better understand how to treat the neurodegenerative condition for which there is currently…
Clinical knowledge about chronic traumatic encephalopathy (CTE) has come a long way, but there is still much to learn about this neurodegenerative disorder caused by repeated head injuries over time.…
A new study led by School of Public Health researchers reveals that the now-expired 2021 CTC expansion benefitted families experiencing financial setbacks due to health or employment challenges spurred by…
Glucagon-like peptide-1 (GLP-1) receptor agonists, a new class of drugs sold under names such as Ozempic, Wegovy, and Zepbound, are soaring in popularity for their ability to achieve and sustain substantial weight loss and improve cardiometabolic health.…
At a time when climate change is causing more frequent and severe natural disasters, as well as a range of other health impacts, it’s essential that researchers, policymakers, and industry…
Over the past few years, and with generous support from alumni and friends, the Boston University School of Public Health has increased its seed funding for faculty-initiated projects that advance…